HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2002
10201	10201 Fillit HN, O'Connell AW, Brown WM, Altstiel LD, Anand R, et al. Barriers to drug discovery and development for Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S1-S8	2	7	6	46
10202	10202 Khachaturian ZS Models and modeling systems in Alzheimer disease drug discovery ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S9-S12	0	1	9	44
10203	10203 Ferris SH Clinical trials in AD: Are current formats and outcome measures adequate? ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S13-S17	0	4	2	51
10204	10204 Altstiel LD Barriers to Alzheimer disease drug discovery and development in the biotechnology industry ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S29-S32	0	1	3	28
10205	10205 Valle R, Lee B Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S64-S76	1	7	2	140
10206	10206 Kakimura J, Kitamura Y, Takata K, Tsuchiya D, Taniguchi T, et al. Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 327-332	0	3	6	19
10207	10207 Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, et al. Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key? AMINO ACIDS. 2002; 23 (1-3): 87-93	7	13	24	59
10208	10208 Ingelsson M, Hyman BT Disordered proteins in dementia ANNALS OF MEDICINE. 2002; 34 (4): 259-271	6	8	54	150
10209	10209 Cacabelos R Pharmacogenomics for the treatment of dementia ANNALS OF MEDICINE. 2002; 34 (5): 357-379	6	28	21	220
10210	10210 Herz J, Bock HH Lipoprotein receptors in the nervous system ANNUAL REVIEW OF BIOCHEMISTRY. 2002; 71: 405-434	3	192	13	205
#	Date / Author / Journal	LCS	GCS	LCR	CR
10211	10211 Annaert W, De Strooper B A cell biological perspective on Alzheimer's disease ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY. 2002; 18: 25-51	23	121	18	156
10212	10212 Gottlieb DI Large-scale sources of neural stem cells ANNUAL REVIEW OF NEUROSCIENCE. 2002; 25: 381-407	12	61	14	102
10213	10213 Lewis DA, Levitt P Schizophrenia as a disorder of neurodevelopment ANNUAL REVIEW OF NEUROSCIENCE. 2002; 25: 409-432	29	319	10	118
10214	10214 Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, et al. The public health impact of Alzheimer's disease 2000-2050: Potential implication of treatment advances ANNUAL REVIEW OF PUBLIC HEALTH. 2002; 23: 213-231	15	102	4	52
10215	10215 Packer L, Obermuller-Jevic UC Vitamin E in disease prevention and therapy: Future perspectives ANTIOXIDANT VITAMINS C AND E. 2002; : 255-288	0	4	4	239
10216	10216 Totterdell S, Lau YS, Petroske E, Callen S, Meredith GE Progressive neurodegeneration in a new mouse model of Parkinson's disease BASAL GANGLIA VII. 2002; 52: 465-474	0	0	4	34
10217	10217 van Roon-Mom WMC, Reid SJ, Faull RLM, Snell RG Immunohistochemical localisation of TATA-binding protein in Huntington's disease cortex BASAL GANGLIA VII. 2002; 52: 481-490	0	0	13	35
10218	10218 Le Belle JE, Svendsen CN Stem cells for Neurodegenerative disorders - Where can we go from here? BIODRUGS. 2002; 16 (6): 389-401	6	28	19	186
10219	10219 Sabate R, Estelrich J Aggregation characteristics of ovalbumin in beta-sheet conformation determined by spectroscopy BIOPOLYMERS. 2002; 67 (2): 113-120	1	5	3	24
10220	10220 Lim PS, Chang YM, Thien LM, Wang NP, Yang CC, et al. 8-iso-prostaglandin F-2 alpha as a useful clinical biomarker of oxidative stress in ESRD patients BLOOD PURIFICATION. 2002; 20 (6): 537-542	0	34	1	42
#	Date / Author / Journal	LCS	GCS	LCR	CR
10221	10221 Alipour M, Chen Y, Jurgens U Anterograde projections of the motorcortical tongue area in the saddle- back tamarin (Saguinus fuscicollis) BRAIN BEHAVIOR AND EVOLUTION. 2002; 60 (2): 101-116	0	11	4	41
10222	10222 Arai H, Higuchi M, Okamura N, Hu XS, Matsui T, et al. An approach to establish antemortem diagnosis of dementia with Lewy bodies CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE. 2002; 53: 525-528	0	0	2	3
10223	10223 Kotwal GJ, Lahiri DK, Hicks R Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS. 2002; 973: 317-322	0	7	7	40
10224	10224 Duan WM, Rodrigures CMP, Zhao LR, Steer CJ, Low WC Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease CELL TRANSPLANTATION. 2002; 11 (3): 195-205	2	24	3	46
10225	10225 Subramanian T, Marchionini D, Potter EM, Cornfeldt ML Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response CELL TRANSPLANTATION. 2002; 11 (3): 207-214	19	34	2	18
10226	10226 Casper D, Engstrom SJ, Mirchandani GR, Pidel A, Palencia D, et al. Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer CELL TRANSPLANTATION. 2002; 11 (4): 331-349	4	19	5	79
10227	10227 Hayashi T, Uchida K, Mine Y, Yamada M, Kawase T Feasibility of using early mesencephalic neural plate for intracerebral grafting CELL TRANSPLANTATION. 2002; 11 (5): 465-470	1	9	7	17
10228	10228 Blits B, Boer GJ, Verhaagen J Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration CELL TRANSPLANTATION. 2002; 11 (6): 593-613	0	26	11	231
10229	10229 Zietlow R, Sinclair SR, Schwiening CJ, Dunnett SB, Fawcett JW The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro CELL TRANSPLANTATION. 2002; 11 (7): 637-652	2	7	3	66
10230	10230 Love RM, Branton RL, Karlsson J, Brundin P, Clarke DJ Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease CELL TRANSPLANTATION. 2002; 11 (7): 653-662	3	15	4	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
10231	10231 Dall AM, Danielsen EH, Sorensen JC, Andersen F, Moller A, et al. Quantitative [F-18]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs CELL TRANSPLANTATION. 2002; 11 (8): 733-746	1	22	5	83
10232	10232 Sato F, Kanno T, Nagasawa S, Yanaihara N, Ishida N, et al. Immunohistochemical localization of chromogranin A in the acinar cells of equine salivary glands contrasts with rodent glands CELLS TISSUES ORGANS. 2002; 172 (1): 29-36	1	7	6	32
10233	10233 Barkhof F, Scheltens P Imaging of white matter lesions CEREBROVASCULAR DISEASES. 2002; 13: 21-30	5	48	4	24
10234	10234 Morrison JH, Hof PR Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease CHANGING VIEWS OF CAJAL'S NEURON. 2002; 136: 467-486	14	79	9	79
10235	10235 Rosenstiel P, Gallinat S, Arlt A, Unger T, Sievers J, et al. Angiotensin AT(2) receptor ligands - Do they have potential as future treatments for neurological disease? CNS DRUGS. 2002; 16 (3): 145-153	0	8	6	73
10236	10236 Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, et al. The role of iron and copper in the aetiology of neurodegenerative disorders - Therapeutic implications CNS DRUGS. 2002; 16 (5): 339-352	17	68	17	120
10237	10237 Vesey R, Birrell JM, Bolton C, Chipperfield RS, Blackwell AD, et al. Cholinergic nicotinic systems in Alzheimer's disease - Prospects for pharmacological intervention CNS DRUGS. 2002; 16 (7): 485-500	2	7	3	141
10238	10238 Saragovi HU, Zaccaro MC Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites CURRENT PHARMACEUTICAL DESIGN. 2002; 8 (24): 2201-2216	1	16	13	169
10239	10239 Jimenez-Escrig A, Fernandez-Lorente J, Herrero A, Baron M, Lousa M, et al. Event-related evoked potential P300 in frontotemporal dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (1): 27-32	0	4	5	35
10240	10240 Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, et al. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (2): 80-90	11	13	2	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
10241	10241 Sjogren M, Davidson P, Wallin A, Granerus AK, Grundstrom E, et al. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (2): 112-118	34	53	21	45
10242	10242 Bronge L, Bogdanovic N, Wahlund LO Postmortem MRI and histopathology of white matter changes in Alzheimer brains - A quantitative, comparative study DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (4): 205-212	10	56	18	43
10243	10243 Hanyu H, Asano T, Tanaka Y, Iwamoto T, Takasaki M, et al. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 1-6	0	9	8	36
10244	10244 Tang-Wai D, Lewis P, Boeve B, Hutton M, Golde T, et al. Familial frontotemporal dementia associated with a novel presenilin-1 mutation DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 13-21	23	39	5	36
10245	10245 Allard P, Englund E, Marcusson J Caudate nucleus dopamine D-2 receptors in vascular dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 22-25	0	1	1	24
10246	10246 Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, Infante J, Berciano J Candidate gene association studies in sporadic Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 41-54	6	28	10	142
10247	10247 Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, et al. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (4): 167-175	11	14	5	36
10248	10248 Nagga K, Gottfries J, Blennow K, Marcusson J Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (4): 183-190	22	33	23	52
10249	10249 Del Rio JA, Barlow C Genomics and neurological phenotypes: applications for seizure-induced damage DO SEIZURES DAMAGE THE BRAIN. 2002; 135: 149-160	0	5	2	14
10250	10250 Jeffrey AM, Luo FQ, Amin S, Krzeminski J, Zech K, et al. Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline DRUG AND CHEMICAL TOXICOLOGY. 2002; 25 (1): 93-107	1	10	1	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
10251	10251 Kung MP, Zhuang ZP, Hou C, Skovronsky D, Gur T, et al. Novel beta-amyloid probes DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 50-56	0	0	4	16
10252	10252 DeBernardis J, Kerkman D, Vianna C, Davies P Phosphorylations of tau and APP as targets for drug discovery DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 116-128	0	0	19	45
10253	10253 Chain DG, Galasko D, Neria E, Pappolla M, Bendheim PE, et al. Antioxidants in the treatment of Alzheimer's disease: Breakthrough potential of indole-3propionic acid DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 159-170	0	0	6	30
10254	10254 Swanberg MM, Cummings JL Benefit-risk considerations in the treatment of dementia with Lewy bodies DRUG SAFETY. 2002; 25 (7): 511-523	4	9	6	112
10255	10255 Korczyn AD, Nussbaum M Emerging therapies in the pharmacological treatment of Parkinson's disease DRUGS. 2002; 62 (5): 775-786	4	12	7	115
10256	10256 McNamara P, Lawson JA, Rokach J, FitzGerald GA Isoprostane activation of the nuclear hormone receptor PPAR EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY, 5. 2002; 507: 351-355	1	11	2	25
10257	10257 Veld BAIT, Launer LJ, Breteler MMB, Hofman A, Stricker BHC Pharmacologic agents associated with a preventive effect on Alzheimer's disease: A review of the epidemiologic evidence EPIDEMIOLOGIC REVIEWS. 2002; 24 (2): 248-268	1	4	3	187
10258	10258 Kim JY, Roh JK, Lee SK, Chung CK Neurotrophin receptor immunoreactivity in severe cerebral cortical dysplasia EPILEPSIA. 2002; 43: 220-226	4	7	3	39
10259	10259 Yeung RS Tuberous sclerosis as an underlying basis for infantile spasm EPILEPSY, INFANTILE SPASMS, AND DEVELOPMENTAL ENCEPHALOPATHY. 2002; 49: 315-332	0	6	5	59
10260	10260 Crino PB Gene expression analysis as a strategy to understand the molecular pathogenesis of infantile spasms EPILEPSY, INFANTILE SPASMS, AND DEVELOPMENTAL ENCEPHALOPATHY. 2002; 49: 367-389	0	2	6	45
#	Date / Author / Journal	LCS	GCS	LCR	CR
10261	10261 Labat ML Human stem cells: Scientific and ethical aspects ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA. 2002; : 67-78	0	0	2	51
10262	10262 Magill G An ethical analysis of the policy implications in the united states emerging from the relationship between human genomics and embryonic stem cell research ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA. 2002; : 191-201	0	0	1	35
10263	10263 Ljungdahl M, Eriksson LG, Nyman R, Gustavssoni S Arterial embolisation in management of massive bleeding from gastric and duodenal ulcers EUROPEAN JOURNAL OF SURGERY. 2002; 168 (7): 384-390	0	23	2	16
10264	10264 Bitsch A, Horn C, Kemmling Y, Seipelt M, Hellenbrand U, et al. Serum tau protein level as a marker of axonal damage in acute ischemic stroke EUROPEAN NEUROLOGY. 2002; 47 (1): 45-51	2	21	8	29
10265	10265 Romi F, Tysnes OB, Krakenes J, Savoiardo M, Aarli JA, et al. Cystic dilation of Virchow-Robin spaces in the midbrain EUROPEAN NEUROLOGY. 2002; 47 (3): 186-188	5	7	3	12
10266	10266 Molina JA, Garcia-Segura JM, Benito-Leon J, Gomez-Escalonilla C, del Ser T, et al. Proton magnetic resonance spectroscopy in dementia with Lewy bodies EUROPEAN NEUROLOGY. 2002; 48 (3): 158-163	10	19	5	31
10267	10267 Stoltenburg-Didinger G Prion diseases FLEISCHWIRTSCHAFT. 2002; 82 (7): 107-110	0	1	2	33
10268	10268 Kowalska A, Takahashi K, Kozubski W, Tabira T Microtubule associated protein (Tau) gene variability in patients with frontotemporal dementia FOLIA NEUROPATHOLOGICA. 2002; 40 (1): 1-5	1	2	22	27
10269	10269 Krygowska-Wajs A, Adamek D, Szczudlik A, Kaluza J An attempt at evaluating borderline conditions of Parkinson's disease and its preclinical stage on the basis of clinical and morphological correlation FOLIA NEUROPATHOLOGICA. 2002; 40 (2): 57-66	0	2	6	19
10270	10270 Kowalska A Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118	3	3	58	81
#	Date / Author / Journal	LCS	GCS	LCR	CR
10271	10271 George JM The synucleins GENOME BIOLOGY. 2002; 3 (1): Art. No. 3002.1	0	26	18	37
10272	10272 Oshiro S A new effect of aluminum on iron metabolism in mammalian cells GROUP 13 CHEMISTRY II. 2002; 104: 59-77	0	0	6	50
10273	10273 Stephan A, Davis S, Salin H, Dumas S, Mallet J, et al. Age-dependent differential regulation of genes encoding APP and alpha- synuclein in hippocampal synaptic plasticity HIPPOCAMPUS. 2002; 12 (1): 55-62	8	14	13	58
10274	10274 Takahashi RH, Nam EE, Edgar M, Gouras GK Alzheimer beta-amyloid peptides: normal and abnormal localization HISTOLOGY AND HISTOPATHOLOGY. 2002; 17 (1): 239-246	7	20	17	68
10275	10275 Crowther DC Familial conformational diseases and dementias HUMAN MUTATION. 2002; 20 (1): 1-14	4	24	42	154
10276	10276 Harvey PD, Moriarty PJ, Bowie C, Friedman JI, Parrella M, et al. Cortical and subcortical cognitive deficits in schizophrenia: Convergence of classifications based on language and memory skill areas JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY. 2002; 24 (1): 55-66	1	8	6	31
10277	10277 Alvarez N, Robledo S, Velez ID, Robert JM, Le Baut G, et al. Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2002; 17 (6): 443-447	0	4	2	19
10278	10278 Yamamoto T, Maruyama W, Kato Y, Yi H, Shamoto-Nagai M, et al. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (1): 1-13	13	54	2	34
10279	10279 Panegyres PK, Zafiris-Toufexis K, Kakulas BA The mRNA of the NRI subtype of glutamate receptor in Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (1): 77-89	0	4	6	51
10280	10280 Wenning GK, Seppi K, Tison F, Jellinger K A novel grading scale for striatonigral degeneration (multiple system atrophy) JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (3): 307-320	20	40	12	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
10281	10281 Jellinger KA, Seppi K, Wenning GK, Poewe W Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (3): 329-339	56	89	3	38
10282	10282 Benninghoff J, Schmitt A, Mossner R, Lesch KP When cells become depressed: focus on neural stem cells in novel treatment strategies against depression JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (5-6): 947-962	3	24	4	89
10283	10283 Windisch M, Hutter-Paier B, Schreiner E Current drugs and future hopes in the treatment of Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 149-164	0	8	26	101
10284	10284 Iqbal K, Alonso AD, El-Akkad E, Gong CX, Haque N, et al. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 309-319	0	5	20	46
10285	10285 Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, et al. Effects of Cerebrolysin (TM) on amyloid-beta deposition in a transgenic model of Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 327-336	0	24	9	45
10286	10286 Jellinger KA Recent developments in the pathology of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 347-376	0	53	49	169
10287	10287 Church SM, Cotter D, Bramon E, Murray RM Does schizophrenia result from developmental or degenerative processes? JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (63): 129-147	1	16	26	166
10288	10288 Roberts SM, Santoro MG, Sickle ES The emergence of the cyclopentenone prostaglandins as important, biologically active compounds JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1. 2002; (15): 1735-1742	0	42	3	106
10289	10289 Burgess JK, McParland BE Analysis of gene expression LASER CAPTURE MICROSCOPY AND MICRODISSECTION. 2002; 356: 259-270	1	3	2	18
10290	10290 Ihara Y Significance of neurofirrillary tangles in Alzheimer's disease - Lessons from frontotemporal dementia and parkinsonism linked to chromosome 17 MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 27-32	0	0	7	9
#	Date / Author / Journal	LCS	GCS	LCR	CR
10291	10291 Kasa P, Papp H, Pakaski M PS-1 is transported from the motoneurons to their axon terminals MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 101-104	0	0	6	11
10292	10292 Gotz J, Chen F, Nitsch RM Interactions of beta-amyloid with the formation of neurofibrillary tangles in transgenic mice MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 139-144	0	0	19	23
10293	10293 Cornelli U, Hanin I, Lorens S, Fareed J, Lee J, et al. Historical overview of glycosaminoglycans (GAGs) and their potential value in the treatment of Alzheimer's disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 145-155	0	0	8	65
10294	10294 Mizuno Y, Hattori N, Shimura H, Kitada T, Kubo S, et al. Etiology, pathogenesis, and genetics of Parkinson's disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 239-244	0	0	13	39
10295	10295 Tsang KL, Feng ZH, Jiang H, Ramsden DB, Ho SL Genetic risk factors in Parkinson's disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 251-257	0	0	9	32
10296	10296 Gwinn-Hardy K, Hanson M, Wszolek Z, Adam A, Singleton A, et al. Familial variants of Parkinson's disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 281-284	0	0	7	19
10297	10297 Elibol B, Kobayashi T, Atac FB, Hattori N, Sahin G, et al. Familial parkinsonism with apathy, depression and central hypoventilation (Perry's syndrome) MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 285-290	0	3	8	16
10298	10298 Schlossmacher MG, Frosch MP, Gai WP, Sharma N, Medina M, et al. Colocalization of parkin with alpha-synuclein in the Lewy bodies of Parkinson disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 297-300	0	0	7	11
10299	10299 Calne DB Progress in the treatment of Parkinson's disease MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 361-364	0	0	1	8
10300	10300 Spillantini MG, Tofaris GK Molecular biology of Lewy body formation - alpha-Synudeinopathies MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 483-489	0	0	46	68

Date / Author / Journal

LCS

GCS

LCR

2002

10201

10201 Fillit HN, O'Connell AW, Brown WM, Altstiel LD, Anand R, et al.

Barriers to drug discovery and development for Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S1-S8

10202

10202 Khachaturian ZS

Models and modeling systems in Alzheimer disease drug discovery

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S9-S12

10203

10203 Ferris SH

Clinical trials in AD: Are current formats and outcome measures adequate?

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S13-S17

10204

10204 Altstiel LD

Barriers to Alzheimer disease drug discovery and development in the biotechnology industry

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S29-S32

10205

10205 Valle R, Lee B

Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002; 16: S64-S76

140

10206

10206 Kakimura J, Kitamura Y, Takata K, Tsuchiya D, Taniguchi T, et al.

Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits

ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 327-332

10207

10207 Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, et al.

Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key?

AMINO ACIDS. 2002; 23 (1-3): 87-93

10208

10208 Ingelsson M, Hyman BT

Disordered proteins in dementia

ANNALS OF MEDICINE. 2002; 34 (4): 259-271

150

10209

10209 Cacabelos R

Pharmacogenomics for the treatment of dementia

ANNALS OF MEDICINE. 2002; 34 (5): 357-379

220

10210

10210 Herz J, Bock HH

Lipoprotein receptors in the nervous system

ANNUAL REVIEW OF BIOCHEMISTRY. 2002; 71: 405-434

192

205

Date / Author / Journal

LCS

GCS

LCR

10211

10211 Annaert W, De Strooper B

A cell biological perspective on Alzheimer's disease

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY. 2002; 18: 25-51

121

156

10212

10212 Gottlieb DI

Large-scale sources of neural stem cells

ANNUAL REVIEW OF NEUROSCIENCE. 2002; 25: 381-407

102

10213

10213 Lewis DA, Levitt P

Schizophrenia as a disorder of neurodevelopment

ANNUAL REVIEW OF NEUROSCIENCE. 2002; 25: 409-432

319

118

10214

10214 Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, et al.

The public health impact of Alzheimer's disease 2000-2050: Potential implication of treatment advances

ANNUAL REVIEW OF PUBLIC HEALTH. 2002; 23: 213-231

102

10215

10215 Packer L, Obermuller-Jevic UC

Vitamin E in disease prevention and therapy: Future perspectives

ANTIOXIDANT VITAMINS C AND E. 2002; : 255-288

239

10216

10216 Totterdell S, Lau YS, Petroske E, Callen S, Meredith GE

Progressive neurodegeneration in a new mouse model of Parkinson's disease

BASAL GANGLIA VII. 2002; 52: 465-474

10217

10217 van Roon-Mom WMC, Reid SJ, Faull RLM, Snell RG

Immunohistochemical localisation of TATA-binding protein in Huntington's disease cortex

BASAL GANGLIA VII. 2002; 52: 481-490

10218

10218 Le Belle JE, Svendsen CN

Stem cells for Neurodegenerative disorders - Where can we go from here?

BIODRUGS. 2002; 16 (6): 389-401

186

10219

10219 Sabate R, Estelrich J

Aggregation characteristics of ovalbumin in beta-sheet conformation determined by spectroscopy

BIOPOLYMERS. 2002; 67 (2): 113-120

10220

10220 Lim PS, Chang YM, Thien LM, Wang NP, Yang CC, et al.

8-iso-prostaglandin F-2 alpha as a useful clinical biomarker of oxidative stress in ESRD patients

BLOOD PURIFICATION. 2002; 20 (6): 537-542

Date / Author / Journal

LCS

GCS

LCR

10221

10221 Alipour M, Chen Y, Jurgens U

Anterograde projections of the motorcortical tongue area in the saddle- back tamarin (Saguinus fuscicollis)

BRAIN BEHAVIOR AND EVOLUTION. 2002; 60 (2): 101-116

10222

10222 Arai H, Higuchi M, Okamura N, Hu XS, Matsui T, et al.

An approach to establish antemortem diagnosis of dementia with Lewy bodies

CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE. 2002; 53: 525-528

10223

10223 Kotwal GJ, Lahiri DK, Hicks R

Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease

CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS. 2002; 973: 317-322

10224

10224 Duan WM, Rodrigures CMP, Zhao LR, Steer CJ, Low WC

Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease

CELL TRANSPLANTATION. 2002; 11 (3): 195-205

10225

10225 Subramanian T, Marchionini D, Potter EM, Cornfeldt ML

Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response

CELL TRANSPLANTATION. 2002; 11 (3): 207-214

10226

10226 Casper D, Engstrom SJ, Mirchandani GR, Pidel A, Palencia D, et al.

Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer

CELL TRANSPLANTATION. 2002; 11 (4): 331-349

10227

10227 Hayashi T, Uchida K, Mine Y, Yamada M, Kawase T

Feasibility of using early mesencephalic neural plate for intracerebral grafting

CELL TRANSPLANTATION. 2002; 11 (5): 465-470

10228

10228 Blits B, Boer GJ, Verhaagen J

Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration

CELL TRANSPLANTATION. 2002; 11 (6): 593-613

231

10229

10229 Zietlow R, Sinclair SR, Schwiening CJ, Dunnett SB, Fawcett JW

The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro

CELL TRANSPLANTATION. 2002; 11 (7): 637-652

10230

10230 Love RM, Branton RL, Karlsson J, Brundin P, Clarke DJ

Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease

CELL TRANSPLANTATION. 2002; 11 (7): 653-662

Date / Author / Journal

LCS

GCS

LCR

10231

10231 Dall AM, Danielsen EH, Sorensen JC, Andersen F, Moller A, et al.

Quantitative [F-18]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs

CELL TRANSPLANTATION. 2002; 11 (8): 733-746

10232

10232 Sato F, Kanno T, Nagasawa S, Yanaihara N, Ishida N, et al.

Immunohistochemical localization of chromogranin A in the acinar cells of equine salivary glands contrasts with rodent glands

CELLS TISSUES ORGANS. 2002; 172 (1): 29-36

10233

10233 Barkhof F, Scheltens P

Imaging of white matter lesions

CEREBROVASCULAR DISEASES. 2002; 13: 21-30

10234

10234 Morrison JH, Hof PR

Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease

CHANGING VIEWS OF CAJAL'S NEURON. 2002; 136: 467-486

10235

10235 Rosenstiel P, Gallinat S, Arlt A, Unger T, Sievers J, et al.

Angiotensin AT(2) receptor ligands - Do they have potential as future treatments for neurological disease?

CNS DRUGS. 2002; 16 (3): 145-153

10236

10236 Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, et al.

The role of iron and copper in the aetiology of neurodegenerative disorders - Therapeutic implications

CNS DRUGS. 2002; 16 (5): 339-352

120

10237

10237 Vesey R, Birrell JM, Bolton C, Chipperfield RS, Blackwell AD, et al.

Cholinergic nicotinic systems in Alzheimer's disease - Prospects for pharmacological intervention

CNS DRUGS. 2002; 16 (7): 485-500

141

10238

10238 Saragovi HU, Zaccaro MC

Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites

CURRENT PHARMACEUTICAL DESIGN. 2002; 8 (24): 2201-2216

169

10239

10239 Jimenez-Escrig A, Fernandez-Lorente J, Herrero A, Baron M, Lousa M, et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (1): 27-32

10240

10240 Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, et al.

Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (2): 80-90

Date / Author / Journal

LCS

GCS

LCR

10241

10241 Sjogren M, Davidson P, Wallin A, Granerus AK, Grundstrom E, et al.

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (2): 112-118

10242

10242 Bronge L, Bogdanovic N, Wahlund LO

Postmortem MRI and histopathology of white matter changes in Alzheimer brains - A quantitative, comparative study

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 13 (4): 205-212

10243

10243 Hanyu H, Asano T, Tanaka Y, Iwamoto T, Takasaki M, et al.

Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 1-6

10244

10244 Tang-Wai D, Lewis P, Boeve B, Hutton M, Golde T, et al.

Familial frontotemporal dementia associated with a novel presenilin-1 mutation

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 13-21

10245

10245 Allard P, Englund E, Marcusson J

Caudate nucleus dopamine D-2 receptors in vascular dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 22-25

10246

10246 Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, Infante J, Berciano J

Candidate gene association studies in sporadic Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (1): 41-54

142

10247

10247 Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, et al.

Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (4): 167-175

10248

10248 Nagga K, Gottfries J, Blennow K, Marcusson J

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002; 14 (4): 183-190

10249

10249 Del Rio JA, Barlow C

Genomics and neurological phenotypes: applications for seizure-induced damage

DO SEIZURES DAMAGE THE BRAIN. 2002; 135: 149-160

10250

10250 Jeffrey AM, Luo FQ, Amin S, Krzeminski J, Zech K, et al.

Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline

DRUG AND CHEMICAL TOXICOLOGY. 2002; 25 (1): 93-107

Date / Author / Journal

LCS

GCS

LCR

10251

10251 Kung MP, Zhuang ZP, Hou C, Skovronsky D, Gur T, et al.

Novel beta-amyloid probes

DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 50-56

10252

10252 DeBernardis J, Kerkman D, Vianna C, Davies P

Phosphorylations of tau and APP as targets for drug discovery

DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 116-128

10253

10253 Chain DG, Galasko D, Neria E, Pappolla M, Bendheim PE, et al.

Antioxidants in the treatment of Alzheimer's disease: Breakthrough potential of indole-3propionic acid

DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000. 2002; : 159-170

10254

10254 Swanberg MM, Cummings JL

Benefit-risk considerations in the treatment of dementia with Lewy bodies

DRUG SAFETY. 2002; 25 (7): 511-523

112

10255

10255 Korczyn AD, Nussbaum M

Emerging therapies in the pharmacological treatment of Parkinson's disease

DRUGS. 2002; 62 (5): 775-786

115

10256

10256 McNamara P, Lawson JA, Rokach J, FitzGerald GA

Isoprostane activation of the nuclear hormone receptor PPAR

EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY, 5. 2002; 507: 351-355

10257

10257 Veld BAIT, Launer LJ, Breteler MMB, Hofman A, Stricker BHC

Pharmacologic agents associated with a preventive effect on Alzheimer's disease: A review of the epidemiologic evidence

EPIDEMIOLOGIC REVIEWS. 2002; 24 (2): 248-268

187

10258

10258 Kim JY, Roh JK, Lee SK, Chung CK

Neurotrophin receptor immunoreactivity in severe cerebral cortical dysplasia

EPILEPSIA. 2002; 43: 220-226

10259

10259 Yeung RS

Tuberous sclerosis as an underlying basis for infantile spasm

EPILEPSY, INFANTILE SPASMS, AND DEVELOPMENTAL ENCEPHALOPATHY. 2002; 49: 315-332

10260

10260 Crino PB

Gene expression analysis as a strategy to understand the molecular pathogenesis of infantile spasms

EPILEPSY, INFANTILE SPASMS, AND DEVELOPMENTAL ENCEPHALOPATHY. 2002; 49: 367-389

Date / Author / Journal

10261

Human stem cells: Scientific and ethical aspects

ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA. 2002; : 67-78

10262

10262 Magill G

An ethical analysis of the policy implications in the united states emerging from the relationship between human genomics and embryonic stem cell research

ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA. 2002; : 191-201

10263

10263 Ljungdahl M, Eriksson LG, Nyman R, Gustavssoni S

Arterial embolisation in management of massive bleeding from gastric and duodenal ulcers

EUROPEAN JOURNAL OF SURGERY. 2002; 168 (7): 384-390

10264

10264 Bitsch A, Horn C, Kemmling Y, Seipelt M, Hellenbrand U, et al.

Serum tau protein level as a marker of axonal damage in acute ischemic stroke

EUROPEAN NEUROLOGY. 2002; 47 (1): 45-51

10265

10265 Romi F, Tysnes OB, Krakenes J, Savoiardo M, Aarli JA, et al.

Cystic dilation of Virchow-Robin spaces in the midbrain

EUROPEAN NEUROLOGY. 2002; 47 (3): 186-188

10266

10266 Molina JA, Garcia-Segura JM, Benito-Leon J, Gomez-Escalonilla C, del Ser T, et al.

Proton magnetic resonance spectroscopy in dementia with Lewy bodies

EUROPEAN NEUROLOGY. 2002; 48 (3): 158-163

10267

10267 Stoltenburg-Didinger G

Prion diseases

FLEISCHWIRTSCHAFT. 2002; 82 (7): 107-110

10268

10268 Kowalska A, Takahashi K, Kozubski W, Tabira T

Microtubule associated protein (Tau) gene variability in patients with frontotemporal dementia

FOLIA NEUROPATHOLOGICA. 2002; 40 (1): 1-5

10269

10269 Krygowska-Wajs A, Adamek D, Szczudlik A, Kaluza J

An attempt at evaluating borderline conditions of Parkinson's disease and its preclinical stage on the basis of clinical and morphological correlation

FOLIA NEUROPATHOLOGICA. 2002; 40 (2): 57-66

10270

10270 Kowalska A

Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118

Date / Author / Journal

10271

The synucleins

GENOME BIOLOGY. 2002; 3 (1): Art. No. 3002.1

10272

10272 Oshiro S

A new effect of aluminum on iron metabolism in mammalian cells

GROUP 13 CHEMISTRY II. 2002; 104: 59-77

10273

10273 Stephan A, Davis S, Salin H, Dumas S, Mallet J, et al.

Age-dependent differential regulation of genes encoding APP and alpha- synuclein in hippocampal synaptic plasticity

HIPPOCAMPUS. 2002; 12 (1): 55-62

10274

10274 Takahashi RH, Nam EE, Edgar M, Gouras GK

Alzheimer beta-amyloid peptides: normal and abnormal localization

HISTOLOGY AND HISTOPATHOLOGY. 2002; 17 (1): 239-246

10275

10275 Crowther DC

Familial conformational diseases and dementias

HUMAN MUTATION. 2002; 20 (1): 1-14

154

10276

10276 Harvey PD, Moriarty PJ, Bowie C, Friedman JI, Parrella M, et al.

Cortical and subcortical cognitive deficits in schizophrenia: Convergence of classifications based on language and memory skill areas

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY. 2002; 24 (1): 55-66

10277

10277 Alvarez N, Robledo S, Velez ID, Robert JM, Le Baut G, et al.

Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2002; 17 (6): 443-447

10278

10278 Yamamoto T, Maruyama W, Kato Y, Yi H, Shamoto-Nagai M, et al.

Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells

JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (1): 1-13

10279

10279 Panegyres PK, Zafiris-Toufexis K, Kakulas BA

The mRNA of the NRI subtype of glutamate receptor in Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (1): 77-89

10280

10280 Wenning GK, Seppi K, Tison F, Jellinger K

A novel grading scale for striatonigral degeneration (multiple system atrophy)

JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (3): 307-320

Date / Author / Journal

LCS

GCS

LCR

10281

10281 Jellinger KA, Seppi K, Wenning GK, Poewe W

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (3): 329-339

10282

10282 Benninghoff J, Schmitt A, Mossner R, Lesch KP

When cells become depressed: focus on neural stem cells in novel treatment strategies against depression

JOURNAL OF NEURAL TRANSMISSION. 2002; 109 (5-6): 947-962

10283

10283 Windisch M, Hutter-Paier B, Schreiner E

Current drugs and future hopes in the treatment of Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 149-164

101

10284

10284 Iqbal K, Alonso AD, El-Akkad E, Gong CX, Haque N, et al.

Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 309-319

10285

10285 Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, et al.

Effects of Cerebrolysin (TM) on amyloid-beta deposition in a transgenic model of Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 327-336

10286

10286 Jellinger KA

Recent developments in the pathology of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 347-376

169

10287

10287 Church SM, Cotter D, Bramon E, Murray RM

Does schizophrenia result from developmental or degenerative processes?

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (63): 129-147

166

10288

10288 Roberts SM, Santoro MG, Sickle ES

The emergence of the cyclopentenone prostaglandins as important, biologically active compounds

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1. 2002; (15): 1735-1742

106

10289

10289 Burgess JK, McParland BE

Analysis of gene expression

LASER CAPTURE MICROSCOPY AND MICRODISSECTION. 2002; 356: 259-270

10290

10290 Ihara Y

Significance of neurofirrillary tangles in Alzheimer's disease - Lessons from frontotemporal dementia and parkinsonism linked to chromosome 17

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 27-32

Date / Author / Journal

LCS

GCS

LCR

10291

10291 Kasa P, Papp H, Pakaski M

PS-1 is transported from the motoneurons to their axon terminals

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 101-104

10292

10292 Gotz J, Chen F, Nitsch RM

Interactions of beta-amyloid with the formation of neurofibrillary tangles in transgenic mice

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 139-144

10293

10293 Cornelli U, Hanin I, Lorens S, Fareed J, Lee J, et al.

Historical overview of glycosaminoglycans (GAGs) and their potential value in the treatment of Alzheimer's disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 145-155

10294

10294 Mizuno Y, Hattori N, Shimura H, Kitada T, Kubo S, et al.

Etiology, pathogenesis, and genetics of Parkinson's disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 239-244

10295

10295 Tsang KL, Feng ZH, Jiang H, Ramsden DB, Ho SL

Genetic risk factors in Parkinson's disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 251-257

10296

10296 Gwinn-Hardy K, Hanson M, Wszolek Z, Adam A, Singleton A, et al.

Familial variants of Parkinson's disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 281-284

10297

10297 Elibol B, Kobayashi T, Atac FB, Hattori N, Sahin G, et al.

Familial parkinsonism with apathy, depression and central hypoventilation (Perry's syndrome)

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 285-290

10298

10298 Schlossmacher MG, Frosch MP, Gai WP, Sharma N, Medina M, et al.

Colocalization of parkin with alpha-synuclein in the Lewy bodies of Parkinson disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 297-300

10299

10299 Calne DB

Progress in the treatment of Parkinson's disease

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 361-364

10300

10300 Spillantini MG, Tofaris GK

Molecular biology of Lewy body formation - alpha-Synudeinopathies

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 483-489

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records